Overall rank by patents
#36,674
Across all tracked assignees
USPTO PatentsView assignee record - 7 granted patents across 10 technology areas, active 2023–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61H (PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFI).
The verdict
Naboso holds 7 US patents across 10 technology areas, rank #36,674 of 50,000 tracked assignees.
Naboso Technology Inc. has been granted 7 US utility patents between 2023 and 2025, placing Naboso Technology Inc. at rank #36,674 across all assignees tracked by PlainPatent. This portfolio spans 10 distinct Cooperative Patent Classification (CPC) subclasses, averaging 6.1 claims per patent with primary concentration in A61H (PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFI). As a US Corporation, Naboso Technology Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Naboso sits between Nyansa, Inc. (7 patents, rank #36,670) and Nanocytomics, Llc (7 patents, rank #36,678) - the closest US assignees by grant volume. The composite Innovation Score of 42.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2023 through 2025, with 7 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Naboso Technology Inc.'s 6.1 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 10 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Naboso Technology Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
NYANSA, INC.
7 patents
NYE Manufacturing Ltd.
7 patents
NYKO TECHNOLOGIES, INC.
7 patents
NaNotics, LLC
7 patents
Nakata Engineering Co., Ltd.
7 patents
NandEXT S.R.L.
7 patents
Nano-Product Engineering, LLC
7 patents
NanoCytomics, LLC
7 patents
Naboso Technology Inc.
7 patents
What this shows Naboso holds 7 patents at rank #36,674, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #36,674 in granted patent volume.
Other assignees with the most granted patents in Naboso's primary technology class.
Naboso's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
42 Top 31% higher than 69% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2023 | 3 | 42.9% |
| 2024 | 2 | 28.6% |
| 2025 | 2 | 28.6% |
Top 10 of 10 technology areas
Overall rank by patents
#36,674
Across all tracked assignees
42.0 out of 100
How to use this portfolio
Naboso's 7 grants land it in the top 31% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.